CHEMBIO DIAGNOSTICS INC (CEMI)

US1635722093 - Common Stock

0.455  +0 (+0.22%)

After market: 0.4311 -0.02 (-5.25%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022
Revenue
YoY % growth
32.47M
-5.77%		47.818M
47.27%		49.522M
3.56%
EBITDA
YoY % growth
-19.25M
-80.07%		-21.074M
-9.48%		-17.849M
15.31%
EBIT
YoY % growth
-21.95M
-74.07%		-24.005M
-9.36%		-20.402M
15.01%
Operating Margin
-67.60%-50.20%-41.20%
EPS
YoY % growth
-1.28
-62.03%		-1.38
-7.81%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2022
Q2Q % growth		 -0.29
-31.82%		-0.21-0.08-35.39%
Q4 2021
Q2Q % growth		 -0.47
-34.29%		-0.21-0.26-124.77%
Q3 2021
Q2Q % growth		 -0.24
14.29%		-0.19-0.05-23.84%
Q2 2021
Q2Q % growth		 -0.45
-12.50%		-0.37-0.08-20.32%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2022
Q2Q % growth		 18.817M
115.79%		12.036M6.781M56.34%
Q4 2021
Q2Q % growth		 20.574M
101.11%		13.821M6.753M48.86%
Q3 2021
Q2Q % growth		 12.058M
17.41%		12.712M-653.56K-5.14%
Q2 2021
Q2Q % growth		 6.462M
26.46%		7.138M-675.89K-9.47%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A